Randox, the UK’s largest diagnostics company, is launching the Randox CertiFly app to process and certify results for pre-departure and day two lateral flow tests.

The app, which uses ID verification technology, is designed to simplify foreign travel and facilitate the efficient transfer of secure and verified information. Its launch coincides with another change in rules for international travellers coming to the UK, who will be required to complete a day two lateral flow test from October 24.

The app is free to download and solely for use with Randox Certifly lateral flow tests. Within the app, users are asked to scan their passport to register and collect their sample using a Randox CertiFly lateral flow testing kit. Travellers can then scan their result and receive a certificate within the app and via email.

Test results are available within 15 minutes and processed using AI software, before being confirmed manually by a healthcare professional. Future versions of the app will feature facial recognition software to further increase security.

Dr Peter FitzGerald, managing director at Randox, said: “COVID-19 has severely impacted the way that we travel but, thankfully, testing technology has been able to help the world open up again.

“Randox has been helping millions of passengers travel safely since the onset of the pandemic by providing innovative testing solutions, like the Randox CertiFly app, that fulfil testing requirements for those who need to travel, while keeping costs as low as possible.”

Each Randox CertiFly lateral flow testing kit has a unique, single-use QR code that can be registered within the app. Testing kits can be purchased from the Randox Health website.

Fintan O’Rourke, head of global partnerships at CertiFly, added: “Technology plays a vital role in ensuring the integrity of COVID-19 testing and that’s why CertiFly has developed an app with Randox to reduce the risks associated with fraudulent testing.

“We have built-in the same verification technology that banks use to eliminate identity fraud and a two-step validation process for test results, with AI analysis followed by verification from a healthcare professional. As restrictions evolve, it is important to maintain rigorous testing standards in support of the UK’s fight against COVID-19, and we are proud to be part of this.”